Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 607

1.

Differential expression of microRNAs in plasma of patients with colorectal cancer: a potential marker for colorectal cancer screening.

Ng EK, Chong WW, Jin H, Lam EK, Shin VY, Yu J, Poon TC, Ng SS, Sung JJ.

Gut. 2009 Oct;58(10):1375-81. doi: 10.1136/gut.2008.167817. Epub 2009 Feb 6.

PMID:
19201770
2.

Plasma miR-21: a potential diagnostic marker of colorectal cancer.

Kanaan Z, Rai SN, Eichenberger MR, Roberts H, Keskey B, Pan J, Galandiuk S.

Ann Surg. 2012 Sep;256(3):544-51. doi: 10.1097/SLA.0b013e318265bd6f.

PMID:
22868372
3.

Serum microRNA-29a is a promising novel marker for early detection of colorectal liver metastasis.

Wang LG, Gu J.

Cancer Epidemiol. 2012 Feb;36(1):e61-7. doi: 10.1016/j.canep.2011.05.002. Epub 2011 Oct 21.

PMID:
22018950
4.

Differential expression of miR-144* as a novel fecal-based diagnostic marker for colorectal cancer.

Kalimutho M, Del Vecchio Blanco G, Di Cecilia S, Sileri P, Cretella M, Pallone F, Federici G, Bernardini S.

J Gastroenterol. 2011 Dec;46(12):1391-402. doi: 10.1007/s00535-011-0456-0. Epub 2011 Aug 24.

PMID:
21863218
5.
6.

MicroRNA expression profiling of exfoliated colonocytes isolated from feces for colorectal cancer screening.

Koga Y, Yasunaga M, Takahashi A, Kuroda J, Moriya Y, Akasu T, Fujita S, Yamamoto S, Baba H, Matsumura Y.

Cancer Prev Res (Phila). 2010 Nov;3(11):1435-42. doi: 10.1158/1940-6207.CAPR-10-0036. Epub 2010 Oct 19.

7.

Clinical significance of human kallikrein 10 gene expression in colorectal cancer and gastric cancer.

Feng B, Xu WB, Zheng MH, Ma JJ, Cai Q, Zhang Y, Ji J, Lu AG, Qu Y, Li JW, Wang ML, Hu WG, Liu BY, Zhu ZG.

J Gastroenterol Hepatol. 2006 Oct;21(10):1596-603.

PMID:
16928223
8.

The expression of microRNA-375 in plasma and tissue is matched in human colorectal cancer.

Xu L, Li M, Wang M, Yan D, Feng G, An G.

BMC Cancer. 2014 Sep 25;14:714. doi: 10.1186/1471-2407-14-714.

9.

miR-150 as a potential biomarker associated with prognosis and therapeutic outcome in colorectal cancer.

Ma Y, Zhang P, Wang F, Zhang H, Yang J, Peng J, Liu W, Qin H.

Gut. 2012 Oct;61(10):1447-53. doi: 10.1136/gutjnl-2011-301122. Epub 2011 Nov 3.

PMID:
22052060
10.

Over- and under-expressed microRNAs in human colorectal cancer.

Motoyama K, Inoue H, Takatsuno Y, Tanaka F, Mimori K, Uetake H, Sugihara K, Mori M.

Int J Oncol. 2009 Apr;34(4):1069-75.

PMID:
19287964
11.
12.

Characterization of global microRNA expression reveals oncogenic potential of miR-145 in metastatic colorectal cancer.

Arndt GM, Dossey L, Cullen LM, Lai A, Druker R, Eisbacher M, Zhang C, Tran N, Fan H, Retzlaff K, Bittner A, Raponi M.

BMC Cancer. 2009 Oct 20;9:374. doi: 10.1186/1471-2407-9-374.

13.

Plasma miR-601 and miR-760 are novel biomarkers for the early detection of colorectal cancer.

Wang Q, Huang Z, Ni S, Xiao X, Xu Q, Wang L, Huang D, Tan C, Sheng W, Du X.

PLoS One. 2012;7(9):e44398. doi: 10.1371/journal.pone.0044398. Epub 2012 Sep 6.

14.

Detection of miR-92a and miR-21 in stool samples as potential screening biomarkers for colorectal cancer and polyps.

Wu CW, Ng SS, Dong YJ, Ng SC, Leung WW, Lee CW, Wong YN, Chan FK, Yu J, Sung JJ.

Gut. 2012 May;61(5):739-45. doi: 10.1136/gut.2011.239236. Epub 2011 Sep 19.

PMID:
21930727
15.
16.

Altered expression of miR-21, miR-31, miR-143 and miR-145 is related to clinicopathologic features of colorectal cancer.

Slaby O, Svoboda M, Fabian P, Smerdova T, Knoflickova D, Bednarikova M, Nenutil R, Vyzula R.

Oncology. 2007;72(5-6):397-402. doi: 10.1159/000113489. Epub 2008 Jan 15.

PMID:
18196926
17.

MicroRNA signatures: novel biomarker for colorectal cancer?

Luo X, Burwinkel B, Tao S, Brenner H.

Cancer Epidemiol Biomarkers Prev. 2011 Jul;20(7):1272-86. doi: 10.1158/1055-9965.EPI-11-0035. Epub 2011 May 6. Review.

18.

Circulating miR-221 directly amplified from plasma is a potential diagnostic and prognostic marker of colorectal cancer and is correlated with p53 expression.

Pu XX, Huang GL, Guo HQ, Guo CC, Li H, Ye S, Ling S, Jiang L, Tian Y, Lin TY.

J Gastroenterol Hepatol. 2010 Oct;25(10):1674-80. doi: 10.1111/j.1440-1746.2010.06417.x.

PMID:
20880178
19.

Detection of blood-borne cells in colorectal cancer patients by nested reverse transcription-polymerase chain reaction for carcinoembryonic antigen messenger RNA: longitudinal analyses and demonstration of its potential importance as an adjunct to multiple serum markers.

Guadagni F, Kantor J, Aloe S, Carone MD, Spila A, D'Alessandro R, Abbolito MR, Cosimelli M, Graziano F, Carboni F, Carlini S, Perri P, Sciarretta F, Greiner JW, Kashmiri SV, Steinberg SM, Roselli M, Schlom J.

Cancer Res. 2001 Mar 15;61(6):2523-32.

20.

Systematic identification and validation of candidate genes for detection of circulating tumor cells in peripheral blood specimens of colorectal cancer patients.

Findeisen P, Röckel M, Nees M, Röder C, Kienle P, Von Knebel Doeberitz M, Kalthoff H, Neumaier M.

Int J Oncol. 2008 Nov;33(5):1001-10.

PMID:
18949363

Supplemental Content

Support Center